|
|
Article: Study Shows MammaPrint(R) Breast Cancer Test Provides Benefits to Patients from Personalized Treatment Regimen.
- Article from:
- PR Newswire
- Article date:
- December 14, 2007
CopyrightCOPYRIGHT 2007 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
- New Lancet Oncology publication provides important insights on the use of MammaPrint(R) Breast Cancer Prognosis Test in clinical practice -
AMSTERDAM, The Netherlands, Dec. 14 /PRNewswire/ -- New research demonstrates that the MammaPrint(R) breast cancer prognosis test was successfully implemented in the diagnostic process of breast cancer patients in community hospitals in The Netherlands. MammaPrint(R) assigned up to one- third of the patients to different risk categories as compared to currently used risk assessment tools. In the majority of these situations, it may lead to a reduction in the use of adjuvant chemotherapy. The findings were published in ...